Aimee N. Iberg, Ph.D.
Affiliations: | 2009 | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Molecular BiologyGoogle:
"Aimee Iberg"Parents
Sign in to add mentor| Mark T. Bedford | grad student | 2009 | The University of Texas Graduate School of Biomedical Sciences at Houston | |
| (From protein microarray to biology: The discovery of epigenetic regulatory molecules.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Higgins JP, Sarkar A, Williams ET, et al. (2020) Abstract P1-18-35: MT-5111, a novel HER2 targeting engineered toxin body, under clinical development to overcome mechanisms of resistance to existing HER2 targeted therapies Cancer Research. 80 |
| Iberg A, Cornelison GL, Howard C, et al. (2020) Abstract 539: Novel engineered toxin bodies targeting SLAMF7 (CS1) Cancer Research. 80: 539-539 |
| Ramos HJ, Brieschke B, LeMar S, et al. (2020) Abstract 3366: In vivo efficacy of a PD-L1 targeted, antigen seeding engineered toxin body Immunology. 80: 3366-3366 |
| Iberg A, Acquaye-Seedah E, Rabia LA, et al. (2020) Abstract 2278: CTLA-4 targeted engineered toxin bodies designed to deplete regulatory T cells (Tregs) Immunology. 80: 2278-2278 |
| Ramos HJ, Sarkar AK, Mar SL, et al. (2019) Abstract 3900: The Safety and efficacy profile of a PD-L1 directed, Engineered Toxin Body, as a novel targeted direct-cell kill approach for the treatment of PD-L1 expressing cancers Cancer Research. 79: 3900-3900 |
| Iberg A, Cornelison GL, Howard C, et al. (2019) Abstract 2984: Design and characterization of bispecific engineered toxin bodies for targeted cancer therapy Cancer Research. 79: 2984-2984 |
| Rothbart SB, Fuchs SM, Nady N, et al. (2012) Abstract 993: A high-throughput peptide array screen of H3K9 methyl effectors identifies UHRF1 as an exception to the “phospho/methyl switch.” Cancer Research. 72: 993-993 |
| Liu H, Galka M, Iberg A, et al. (2010) Systematic identification of methyllysine-driven interactions for histone and nonhistone targets. Journal of Proteome Research. 9: 5827-36 |
| Iberg AN, Espejo A, Cheng D, et al. (2008) Arginine methylation of the histone H3 tail impedes effector binding. The Journal of Biological Chemistry. 283: 3006-10 |